Skip to Content
  • Home
  • People
  • Interfering with fat metabolism to improve the efficacy of myeloma therapy.

Interfering with fat metabolism to improve the efficacy of myeloma therapy.

Funder: Leukaemia & Myeloma Research UK Ltd
Duration: May 2024 - October 2025

People

Name Telephone Email Office
Dr Concetta Bubici Dr Concetta Bubici
Senior Lecturer
(Principal investigator)
T: +44 (0)1895 266544
E: concetta.bubici@brunel.ac.uk
 +44 (0)1895 266544 concetta.bubici@brunel.ac.uk Heinz Wolff 129

Outputs

Almarzouq, A., Kaci, FN., Lepore, A., Besse, A., Mohammad, A., Zhang, X., et al. (2025) 'Rewiring lipid metabolism: A novel approach to overcome drug resistance in multiple myeloma'.67th American Society of Hematology (ASH) Annual Meeting. Orlando, FL, USA. 3 - 9 December. American Society of Hematology. pp. 7459 - 7459. ISSN: 0006-4971 Open Access Link

Conference paper

Kaci, FN., Lepore, A., Mohammad, A., Almarzouq, A., Craghill, I., Driessen, C., et al. (2024) 'Targeting Fatty Acid Oxidation Pathways to Overcome Proteasome Inhibitor Resistance in Multiple Myeloma'.Abstract book of the Josep Carreras Leukaemia Research Institute Symposium: Updates on Genetics and Epigenetics of Haematological Malignancies: From Knowledge to Applications. Badalona, Barcelona. 20 - 22 November. Abstract book of the. pp. 73 - 73.Open Access Link

Conference paper